| 000 | 01818 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517113534.0 | ||
| 264 | 0 | _c20180213 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1464-5491 | ||
| 024 | 7 |
_a10.1111/dme.13256 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodbard, H W | |
| 245 | 0 | 0 |
_aSafety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial. _h[electronic resource] |
| 260 |
_bDiabetic medicine : a journal of the British Diabetic Association _c02 2017 |
||
| 300 |
_a189-196 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin, Long-Acting _xtherapeutic use |
| 650 | 0 | 4 |
_aLiraglutide _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xtherapeutic use |
| 700 | 1 | _aBode, B W | |
| 700 | 1 | _aHarris, S B | |
| 700 | 1 | _aRose, L | |
| 700 | 1 | _aLehmann, L | |
| 700 | 1 | _aJarlov, H | |
| 700 | 1 | _aThurman, J | |
| 773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 34 _gno. 2 _gp. 189-196 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dme.13256 _zAvailable from publisher's website |
| 999 |
_c26384984 _d26384984 |
||